Skip to content

Impact of Umbilical Cord Clamping Time on Infant Anemia

Impact of Umbilical Cord Clamping Time on Infant Anemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04463485
Enrollment
65
Registered
2020-07-09
Start date
2017-12-21
Completion date
2018-12-30
Last updated
2020-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Infant Conditions, Third Stage of Labor, Umbilical Cord Clamping Time

Keywords

umbilical cord, clamping, infant, anemia, midwifery

Brief summary

This research was conducted to carry out the effect of umbilical cord clamping time on baby anemia.

Detailed description

This study is an experimental, randomized controlled study. The sample of the study consisted of 65 pregnant women and newborns (intervention=32, control=33) who applied for delivery at Ege University Medical Hospital Gynecology and Obstetrics Clinic at the time of the study. In this study, Descriptive Data Form of Impact of Umbilical Cord Clamping Time on Infant Anemia was used as a data collection tool. In the intervention group waited 60 seconds for umbilical cord clamping in the second stage of labor, in the control group the umbilical cord was clamped in the first 15 seconds. For the data of the first stage of the study, the neonatal hematocrit and bilirubin measurements and the need for phototherapy due to hyperbilirubinemia were evaluated 48 hours after birth. In the second stage of the study, data on anaemia screening performed in family medicine at the end of the fourth month of birth were examined. Statistical analysis of the data from the study was performed using IBM SPSS Statistics 25.0 package program. Parametric tests were used for statistical analysis of the data with a normal distribution. The level of statistical significance was determined as p\<0.05.

Interventions

PROCEDUREDelayed Clamping

Umbilical cord clamping was delayed 60 seconds at the end of second stage of labor.

Sponsors

Mersin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Apply for normal birth * Singleton pregnancy and live fetus * Cephalic presentation * Estimated birth weight between 2500-4000 grams * Birth rates \<5 * Women who received iron support during pregnancy * Haemoglobin level ≥ 11 gr/dL * No systemic disease or pregnancy complication that may pose a risk for postpartum bleeding. * Neonates who don't need for resuscitation after birth * Babies who did not receive iron supplements up to the 4th month after birth were included.

Exclusion criteria

* Pregnant women who refuse to participate in the research * Neonates who need for resuscitation after birth * Babies who receive iron supplements up to the 4th month after birth were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Neonatal Haematocrit Value at 48th Hours of Life48th hours after birthHaematocrit measurement in capillary blood taken from newborn after birth
Neonatal Bilirubin Value at 48th Hours of Life48th hours after birthBilirubin measurement in capillary blood taken from newborn after birth
Phototherapy Requirement Rates due to Hyperbilirubinemia3 or 14 days of ageNeonatal phototherapy requirement due to hyperbilirubinemia in the postpartum period
Haemoglobin Values of 4 Month InfantsInfants' 4th month of ageHaemoglobin measurement at baby's 4th month of age
Haematocrit Values of 4 Month InfantsInfants' 4th month of ageHaematocrit measurement at baby's 4th month of age
Diagnosis of Anemia Rates of 4 Month InfantsInfants' 4th month of ageScreening of the family medicine center, condition of the baby diagnosed with anemia at 4th month of age

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026